Claims for Patent: 5,283,067

Summary for Patent: 5,283,067

Title:	Parenteral suspensions
Abstract:	The invention relates to a dry formulation, in particular a dry formulation obtainable by lyophilisation, which is suitable for the preparation of a stable, aqueous suspension for the parenteral administration of a diclofenac salt. The dry formulation contains a pharmaceutically acceptable and micronised salt of diclofenac and optional pharmaceutically acceptable adjuvants.
Inventor(s):	Geller; Leo (Riehen, CH), Glanzmann; Peter (Basel, CH)
Assignee:	Ciba-Geigy Corporation (Ardsley, NY)
Application Number:	08/017,366
Patent Claims:	1. A suspension administrable to humans by intramuscular injection consisting essentially of: (a) 1-3 ml of sterile water; and (b) 25-150 mg of a sterile, lyophilized formulation of micronized diclofenac sodium and at least one pharmaceutically acceptable adjuvant for establishing isotonic conditions selected from the group consisting of sodium chloride, sorbitol, mannitol and glucose. 2. A process for the preparation of a suspension administrable to humans by intramuscular injection which process steps are consisting essentially of: (a) preparing a sterile, lyophilized formulation of diclofenac sodium in micronized crystal form and at least one pharmaceutically acceptable adjuvant for establishing isotonic conditions selected from the group consisting of sodium chloride, sorbitol, mannitol and glucose; (b) adding 1-3 ml of sterile water; and (c) suspending the lyophilized formulation.

Details for Patent 5,283,067

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2011-02-01